A complaint was filed some months ago within Nevada district courts by Relmada Therapeutics. The complaint was since been amended and a temporary injunction has also been filed. Relmada claims that Laidlaw is in breach of contract and also seeks restitution against this company for unpaid costs and fees. While this seems on the surface to be an adverse finding, Laidlaw remains strong and unbowing in its dedication to stockholders and its company. A letter sent to shareholders concerning this matter reflects this and focuses on moving forward positively. Learn more about this here, “Relmada Therapeutics Files Amended Complaint Against Laidlaw and Its Principals, Matthew Eitner and James Ahern“.
James Ahern (Laidlaw) is a recognized figure in New York as well. Ahern attended college in New York. He has also been in business within the world of finance for over a decade, and his clients know him for being both considerate of their interests and sharply intuitive in business at the same time. While these complaints seem to pose temporary roadblocks for Laidlaw, the future is looking bright and promising for these trailblazers to forge on ahead!